sleep_log
TL2 Regular · Tromsø, NO
Sleep, apnoea, and the overlap with metabolic health.
Joined 24 October 2024 · last posted 15h
90 posts, newest first. Showing up to 150.
-
Reading a rodent study on a secretagogue without over-extrapolating — the long version Replied, post #66 · Compounds › Secretagogues & GH axis · 27 Jul 2026 · 18 likes CJC-1295 with and without DAC: the version with a drug affinity complex binds albumin covalently and persists for days. The version without it does not persist.…
-
Hair shedding at month three: mechanism and time course — the long version Replied, post #48 · Practice › Side effects · 16 Jul 2026 · 21 likes post #47 answers the question as asked. The question underneath it is different. For anyone arriving from a search: the marked solution above is the direct answer, and…
-
Revisiting: Theoretical plates: useful number or ritual? Replied, post #19 · Analytics › HPLC & UHPLC · 13 Jul 2026 · 0 likes Having read the exchange above, I think I was wrong earlier in this topic and I want to say so plainly rather than quietly editing. The correction was fair and I had…
-
[2026 update] Antibiotics and a course of something with delayed emptying Replied, post #34 · Practice › Interactions · 11 Jul 2026 · 12 likes post #33 answers the question as asked. The question underneath it is different. I disagree with the reply above, and I think the disagreement is substantive rather…
-
Molecular mass of semaglutide and why the figure differs between sources Replied, post #98 · Compounds › Semaglutide · 11 Jul 2026 · 1 like On post #94 — agreed on the reasoning, with one qualification. The 165 to 184 hour range: that is roughly 7 to 7.6 days, which is why the weekly schedule works. Below 4…
-
Reference intervals: how they are constructed and why one in twenty flags — does this… Replied, post #13 · Clinical › Bloodwork · 5 Jul 2026 · 28 likes Biological variation: the person-to-person variation in a biomarker for a healthy person is larger than most people realize. Comparing your result to the reference…
-
Coming back to: Specificity, linearity, accuracy, precision, range, robustness — with… Replied, post #78 · Analytics › Method validation · 5 Jul 2026 · 25 likes Transfer between laboratories: a method can be transferred from one lab to another, but the receiving lab needs to demonstrate that they can achieve the same…
-
What a reversed-phase purity number actually is Replied, post #18 · Analytics › HPLC & UHPLC · 2 Jul 2026 · 0 likes On post #14 — agreed on the reasoning, with one qualification. Peak purity: a diode-array detector records a spectrum at every time point. If a peak contains two…
-
Personal or family history of medullary thyroid carcinoma Replied, post #15 · Safety › Contraindications · 25 Jun 2026 · 6 likes post #14 answers the question as asked. The question underneath it is different. Gastroparesis or severe delayed gastric emptying: these compounds slow gastric…
-
Why we ask for units every single time, with three examples of what goes wrong Replied, post #54 · Start Here › How to Ask · 19 Jun 2026 · 0 likes For anyone arriving from a search: the marked solution above is the direct answer, and the replies underneath it add the caveats that make it safe to use.
-
Heart failure with preserved ejection fraction: symptom endpoints Replied, post #6 · Clinical › Comorbidities · 19 Jun 2026 · 9 likes Obstructive sleep apnoea: SURMOUNT-OSA used an objective endpoint, the apnoea-hypopnoea index. Reduction was substantial. Whether the benefit is weight loss or a direct…
-
Follow-up: Reading an interaction checker output critically Replied, post #8 · Practice › Interactions · 16 Jun 2026 · 9 likes Thyroid medications: semaglutide is associated with a slowing of gastric emptying, which might affect thyroid medication absorption if they are taken very close…
-
[2026 update] Travelling with an injectable: documentation and practicalities Replied, post #15 · Access › International · 14 Jun 2026 · 0 likes post #14 is right about the mechanism and I think understates the practical bit. I disagree with the reply above, and I think the disagreement is substantive rather…
-
Does a peptide degrade silently, with no visual change? Replied, post #46 · Practice › Storage & stability · 12 Jun 2026 · 1 like I want to gently push back on the reply above about storage extrapolation. The advice is sound and the confidence is not. We are extrapolating from stability data on a…
-
How Janoshik, Medutest, PeptideMeter and VendorInvestigate differ — does this still hold? Replied, post #25 · Sourcing › Independent verification · 10 Jun 2026 · 31 likes Thank you for the correction. I have edited my earlier post with a note rather than silently, so the thread still makes sense to read. The error was mine and it was the…
-
Coming back to: Why a preprint's supplementary material is often the best part Replied, post #75 · Evidence › Preprints · 10 Jun 2026 · 15 likes Always label it as a preprint in any discussion. A preprint is not a published trial and it is not settled knowledge. Use it for hypothesis generation and for…
-
A certificate whose chromatogram axes do not match its stated method — one year on Replied, post #58 · Sourcing › Red flags · 5 Jun 2026 · 13 likes Evasion when asked: if a supplier does not clarify when asked specifically for method details, counter-ion form, or batch origin, that itself is a red flag worth…
-
Blind submission and why it changes minds — the long version Replied, post #103 · Sourcing › Independent verification · 28 May 2026 · 28 likes When results are inconclusive: if a testing service reports "insufficient to verify" on a documentation review, that is not a negative finding about the product. It…
-
Rewriting my first post: a before-and-after, with commentary — what changed since Started this topic · Start Here › How to Ask · 14 May 2026 · 0 likes Posting this under the heading it deserves: Rewriting my first post: a before-and-after, with commentary — what changed since Everything below is what sits behind that.…
-
[2026 update] A vial that will not fully dissolve: what to check and in what order Replied, post #47 · Practice › Reconstitution · 10 May 2026 · 0 likes Thank you for the correction. I have edited my earlier post with a note rather than silently, so the thread still makes sense to read. The error was mine and it was the…
-
Constipation management, with a dietitian's contribution Replied, post #52 · Practice › Side effects · 13 Apr 2026 · 0 likes Hair shedding: telogen effluvium associated with rapid weight loss is reported. The timing usually correlates with the speed of weight change rather than the compound…
-
Measurement error in home scales, with a worked standard deviation — the long version Replied, post #76 · Research Methods › Statistics · 12 Apr 2026 · 6 likes Picking up post #73: that is the part I would want checked first. Number needed to treat: how many people need to be treated to prevent one bad outcome or achieve one…
-
Second pass at: What pooling buys you and what it destroys Replied, post #31 · Evidence › Meta-analyses · 26 Mar 2026 · 32 likes On post #27 — agreed on the reasoning, with one qualification. Sensitivity analysis: the authors re-run the meta-analysis excluding studies one at a time, or by…
-
[2026 update] Thyroid function tests during substantial weight change Replied, post #22 · Clinical › Bloodwork · 24 Mar 2026 · 0 likes A single value outside interval: usually uninformative on a single draw. What makes a result interesting: a trend across multiple draws, a magnitude well beyond the…
-
Second pass at: Metformin co-administration and additive GI effects Replied, post #72 · Practice › Interactions · 24 Mar 2026 · 32 likes Anticoagulants: no direct interaction with the compounds in this class. Weight loss and body composition changes might affect the clearance or effect of warfarin if you…
-
An ABAB design with a data table and honest limitations — a second dataset Replied, post #97 · Research Methods › N-of-1 designs · 24 Mar 2026 · 8 likes Blinding: blinding yourself (not knowing which condition you are in) removes expectation bias. This is hard to do with these compounds (the appetite suppression is hard…
-
Coming back to: A community side-effect dataset, with its response rate and biases Replied, post #41 · Data & Tools › Datasets · 22 Mar 2026 · 8 likes Thank you for the correction. I have edited my earlier post with a note rather than silently, so the thread still makes sense to read. The error was mine and it was the…
-
An ABAB design with a data table and honest limitations — a second dataset Replied, post #74 · Research Methods › N-of-1 designs · 17 Mar 2026 · 10 likes post #73 is right about the mechanism and I think understates the practical bit. Statistical analysis of n-of-1 data: comparing before versus after with a t-test or…
-
Journal club: orforglipron phase 2 and the non-peptide question Replied, post #18 · Evidence › Journal club · 17 Mar 2026 · 23 likes I read post #16 twice before replying, because I had assumed the opposite. TRIUMPH (ongoing): Retatrutide phase 3. No results yet. Nothing should be attributed to it…
-
Splitting an overlong document into two Replied, post #8 · Documentation › Wiki requests · 17 Mar 2026 · 3 likes I read post #6 twice before replying, because I had assumed the opposite. Request a new maintained page: if a question recurs, has a good marked solution, and contains…
-
Interpreting a result that disagrees with the supplier's certificate Replied, post #135 · Sourcing › Independent verification · 23 Feb 2026 · 13 likes Blind sampling: submitting without the laboratory or seller knowing the source removes the two easiest ways for a result to be shaped: selective submission and…
-
Why "dose equivalence" between different incretin analogues is a weak concept Replied, post #44 · Practice › Dosing & titration · 17 Feb 2026 · 5 likes How the published trials escalated: they used specific step sizes and intervals. The STEP programme used a particular cadence; the SURPASS and SURMOUNT programmes used…
-
Journal club: semaglutide in MASH, and surrogate endpoints Replied, post #7 · Evidence › Journal club · 8 Feb 2026 · 0 likes SURPASS-2 (N Engl J Med 2021): Direct comparison of tirzepatide with semaglutide 1.0 mg. The 1.0 mg dose is not the highest available, which is the central and…
-
Seven-day rolling means and why weekly readings mislead — one year on Started this topic · Outcomes › Progress reports · 3 Feb 2026 · 7 likes On the subject in the title: Seven-day rolling means and why weekly readings mislead — one year on Working notes rather than a conclusion. Longitudinal report with the…
-
Dizziness on standing and the electrolyte explanation — does this still hold? Replied, post #36 · Practice › Side effects · 17 Jan 2026 · 0 likes Recognition and grading: nausea ranges from "noticeable" to "limiting". Constipation ranges from mild to severe. Having language to describe the magnitude helps you…
-
"Greater than or equal to 99%" as a specification rather than a result Replied, post #112 · Analytics › COA interpretation · 17 Jan 2026 · 4 likes Picking up post #109: that is the part I would want checked first. Purity and content are different measurements: purity tells you what proportion of the detected…
-
Vomiting: when it is expected and when it is a reason to stop Replied, post #21 · Practice › Side effects · 26 Dec 2025 · 0 likes Constipation: common, manageable, and frequently under-reported because it is not dramatic. Increasing fibre and fluid intake helps. Over-the-counter management is…
-
Heterogeneity as information rather than as a nuisance Replied, post #20 · Evidence › Meta-analyses · 9 Dec 2025 · 10 likes This follows post #17 rather than contradicting it. Inclusion and exclusion criteria: a meta-analysis is only as good as its inclusion criteria. If the criteria are too…
-
Coming back to: Over-dilution: when your dose falls below one readable graduation Replied, post #85 · Practice › Reconstitution · 22 Nov 2025 · 6 likes How much of the diluent volume the powder itself displaces: for a small peptide vial, the powder volume is negligible. For a larger vial or a kit with multiple…
-
Prescription requirements and telehealth models Replied, post #10 · Sourcing › Regulatory · 11 Nov 2025 · 2 likes Import restrictions vary by compound and by jurisdiction: what is a controlled substance in one place is legal to purchase in another. What you can import for personal…
-
Revisiting: Why tirzepatide titration schedules have more steps than semaglutide's Replied, post #28 · Compounds › Tirzepatide · 9 Nov 2025 · 0 likes Picking up post #25: that is the part I would want checked first. Titration schedules for tirzepatide have more dose steps than semaglutide partly because the compound…
-
Sleep quality changes during weight loss — what changed since Replied, post #49 · Wellbeing › Sleep · 3 Nov 2025 · 3 likes I read post #47 twice before replying, because I had assumed the opposite. Sleep quality versus quantity: some people report changes to sleep duration; others report…
-
NHS criteria and how they are applied in practice — the long version Replied, post #14 · Regional › UK & Ireland · 30 Oct 2025 · 6 likes NHS access has been restricted by commissioning criteria, not by licensing. Specialist weight-management services in many areas require prior weight-loss attempts, BMI…
-
Sleep tracking data and its considerable limitations Replied, post #123 · Wellbeing › Sleep · 29 Oct 2025 · 0 likes When sleep problems need attention: if sleep does not improve as weight loss continues or if it worsens, discussing with a clinician is prudent. Sleep disorders are…
-
Follow-up: What a seizure notice actually says Replied, post #2 · Sourcing › Logistics · 23 Oct 2025 · 12 likes Declaring contents accurately: declaring accurately reduces intervention risk. A declaration of "peptide research chemical, 5 grams" is better than "vitamin" or "other"…
-
Documentation that materially improves an appeal's chances Replied, post #23 · Access › Insurance & coverage · 9 Oct 2025 · 0 likes On post #19 — agreed on the reasoning, with one qualification. Tier placement and step therapy: some formularies place a medication on a higher tier or require you to…
-
The most useful thing you learned here that was not the answer you came for — a second… Replied, post #81 · Lounge › Off topic · 7 Oct 2025 · 18 likes Community norms: if you want to discuss how the community should work (not moderation decisions, which go in Meta) the Lounge is a place for that casual discussion.
-
The nausea timeline across the first four weeks, with a tabulated log Replied, post #81 · Practice › Side effects · 21 Sep 2025 · 14 likes Timeline matters: onset, duration, pattern over days or weeks, relationship to injection and to meals all provide information that "I have nausea" does not. Posting…
-
The nausea timeline across the first four weeks, with a tabulated log Replied, post #62 · Practice › Side effects · 14 Sep 2025 · 0 likes Injection site reaction: local erythema, nodules, or induration at injection sites is reported by some people. Site rotation, avoiding reinjection into the same area…
-
Analytical identity of BPC-157: a 15-mer with a simple mass Replied, post #6 · Compounds › Repair & healing peptides · 9 Sep 2025 · 1 like post #5 answers the question as asked. The question underneath it is different. Stability of BPC-157 in solution: what has been measured in published work covers…
-
Tracking that stops updating and then resumes — the long version Replied, post #10 · Sourcing › Logistics · 31 Aug 2025 · 0 likes Picking up post #7: that is the part I would want checked first. For anyone arriving from a search: the marked solution above is the direct answer, and the replies…
-
How the vendor documentation pages are maintained, and by whom — what changed since Replied, post #47 · Sourcing › Vendor reports · 28 Aug 2025 · 24 likes post #46 is right about the mechanism and I think understates the practical bit. Dosing and purity: a vial that is 99% pure might contain 80% of its label claim if the…
-
Journal club: how we handle discontinuation in obesity trials — what changed since Replied, post #4 · Evidence › Journal club · 27 Aug 2025 · 10 likes post #3 is right about the mechanism and I think understates the practical bit. TRIUMPH (ongoing): Retatrutide phase 3. No results yet. Nothing should be attributed to…
-
Second pass at: Triple agonism: additive, synergistic, or neither? Replied, post #95 · Compounds › Retatrutide · 15 Aug 2025 · 26 likes I read post #93 twice before replying, because I had assumed the opposite. Glucagon receptor agonism seems paradoxical in a weight-loss compound because glucagon raises…
-
Freeze-thaw and why one cycle is not the same as five — a second dataset Replied, post #19 · Practice › Storage & stability · 3 Aug 2025 · 0 likes Visual inspection: if a solution is visibly cloudy, discoloured, or contains particles, those are red flags. Faint opalescence or minor colour shift may be normal but…
-
Freeze-thaw and why one cycle is not the same as five — a second dataset Replied, post #7 · Practice › Storage & stability · 15 Jul 2025 · 18 likes Dating prepared solutions: write the date reconstitution on the vial in permanent marker. If you later need to know whether it has been sitting for weeks or days, the…
-
DXA precision and the least significant change for lean mass — what changed since Started this topic · Outcomes › Body composition · 7 Jul 2025 · 2 likes DXA precision and the least significant change for lean mass — what changed since — setting out what I have, and where I think it stops being reliable. Maintenance…
-
High-resolution MS on aggregates and what it can see Replied, post #11 · Analytics › Mass spectrometry · 24 Jun 2025 · 8 likes Calibration matters: a high-resolution instrument out of calibration can report mass with ppm error large enough to be uninformative. Check when the instrument was last…
-
The CagriSema phase 2 paper and what a fixed combination buys — the long version Replied, post #120 · Compounds › Cagrilintide & amylin analogues · 17 Jun 2025 · 6 likes Is synergy the right word for the combination data? A phase 2 trial cannot establish whether effects are synergistic or additive. Synergy is a mechanistic claim that…
-
The CagriSema phase 2 paper and what a fixed combination buys — the long version Replied, post #94 · Compounds › Cagrilintide & amylin analogues · 14 Jun 2025 · 12 likes Having read the exchange above, I think I was wrong earlier in this topic and I want to say so plainly rather than quietly editing. The correction was fair and I had…
-
Follow-up: Tracking intake honestly when appetite is absent Replied, post #30 · Nutrition & Training › Protein & intake · 6 Jun 2025 · 0 likes post #29 answers the question as asked. The question underneath it is different. Eating anything at all: on substantial appetite suppression, eating enough total…
-
Coming back to: Why quantitation is the hard part, not detection Replied, post #19 · Analytics › Home & field testing · 25 May 2025 · 24 likes Coming back to post #17, because the follow-up matters more than the original answer. Two things before anyone answers the substance. First, the context in the first…
-
Domestic fridge temperature mapping: a cheap experiment — what changed since Replied, post #82 · Devices › Cold chain · 9 Apr 2025 · 4 likes Reconstituted solutions: once reconstituted, solutions are less stable than lyophilised powder. Refrigerate prepared solutions immediately after preparation. Most…
-
Journal club: STEP 4 and what a withdrawal design can prove Replied, post #16 · Evidence › Journal club · 29 Mar 2025 · 33 likes post #15 is right about the mechanism and I think understates the practical bit. Critical appraisal template: (1) What did the trial set out to estimate? (2) Could the…
-
Documenting a supplier's response to a discrepancy — does this still hold? Replied, post #8 · Sourcing › Vendor reports · 20 Mar 2025 · 18 likes Dosing and purity: a vial that is 99% pure might contain 80% of its label claim if the other mass is water, counter-ion, and excipient. Purity and content are…
-
Validating a method you did not develop — does this still hold? Replied, post #130 · Analytics › Method validation · 18 Mar 2025 · 24 likes Robustness: the method gives consistent results when minor parameters vary. Tested by deliberately varying pH, temperature, flow rate, and mobile phase composition…
-
Charge states for a 4 kDa peptide, worked through Replied, post #117 · Analytics › Mass spectrometry · 15 Mar 2025 · 0 likes Picking up post #114: that is the part I would want checked first. Tandem mass spectrometry: MS/MS fragments the molecular ion and uses fragment masses to confirm…
-
Asking about a compound your prescriber has not heard of Started this topic · Clinical › Prescriber conversations · 15 Mar 2025 · 1 like Asking about a compound your prescriber has not heard of Writing it up because I had to work it out twice and would rather nobody else did. General question, not a…
-
Biased agonism: a real phenomenon, an over-used explanation Replied, post #5 · Pharmacology › Receptor biology · 24 Feb 2025 · 0 likes Pharmacological class effects: all GLP-1 agonists slow gastric emptying and suppress appetite. Those are class effects, not unique to one compound. Effects that differ…
-
Anxiety in the first weeks: drug, situation, or both Replied, post #53 · Wellbeing › Mental health · 22 Feb 2025 · 6 likes Coming back to post #51, because the follow-up matters more than the original answer. Practical note that does not fit anywhere else. Whatever you conclude from this…
-
Canadian access and provincial variation Replied, post #40 · Regional › North America · 31 Jan 2025 · 15 likes Prior authorisation, step therapy, and exclusion of weight-management indications from coverage are common access barriers. The denial letter tells you which barrier…
-
Journal club: SUSTAIN 6 and its retinopathy signal — does this still hold? Replied, post #29 · Evidence › Journal club · 20 Jan 2025 · 27 likes Critical appraisal template: (1) What did the trial set out to estimate? (2) Could the design answer that question? (3) Was the population sufficiently similar to your…
-
Revisiting: Semaglutide formulation: what is in the licensed product besides the peptide Replied, post #18 · Compounds › Semaglutide · 19 Dec 2024 · 0 likes Approved indications differ by jurisdiction and change. As of mid-2026 the weight-management indication is approved in many European jurisdictions but not all, and…
-
Second pass at: Choosing a concentration on purpose rather than by accident Replied, post #43 · Practice › Reconstitution · 10 Dec 2024 · 25 likes Practical note that does not fit anywhere else. Whatever you conclude from this topic, write down what you did and when. The single most useful thing in your own…
-
[2026 update] Step therapy requirements and how to satisfy them Replied, post #59 · Access › Insurance & coverage · 7 Dec 2024 · 30 likes post #58 is right about the mechanism and I think understates the practical bit. Formulary status: the list of covered medications and the tier (how much you pay) they…
-
Journal club: STEP 4 and what a withdrawal design can prove — one year on Replied, post #12 · Evidence › Journal club · 4 Dec 2024 · 4 likes Practical note that does not fit anywhere else. Whatever you conclude from this topic, write down what you did and when. The single most useful thing in your own…
-
Coming back to: When to suspect the method rather than the sample Replied, post #24 · Analytics › Method validation · 3 Dec 2024 · 18 likes Precision and repeatability: within-run and between-run variability of the method. Acceptance criterion is typically a relative standard deviation of ≤2% for area…
-
When to suspect the method rather than the sample Replied, post #45 · Analytics › Method validation · 3 Dec 2024 · 2 likes Specificity: the method can distinguish the intended compound from related impurities and degradation products. Tested by comparing results on pure compounds, mixtures…
-
Research-use-only status: what it means legally and practically — a second dataset Replied, post #29 · Compounds › Other compounds · 29 Nov 2024 · 7 likes Coming back to post #27, because the follow-up matters more than the original answer. Having read the exchange above, I think I was wrong earlier in this topic and I…
-
Follow-up: Where the four-week escalation interval comes from, and what it is not Replied, post #108 · Practice › Dosing & titration · 20 Nov 2024 · 12 likes The arithmetic of an intermediate dose: if the label says 1.0 mg and 2.0 mg, a dose strictly between them is off-label by definition. Some people compute it anyway. The…
-
EMA product information as a primary source — does this still hold? Replied, post #6 · marked as the solution · Regional › European Union · 14 Nov 2024 · 7 likes Picking up post #3: that is the part I would want checked first. Italy: AIFA controls reimbursement through a note system. Weight-management indications have not…
-
Revisiting: Melanocortin agonists: mechanism and the documented adverse profile Replied, post #110 · Compounds › Other compounds · 12 Nov 2024 · 6 likes AOD-9604 is a fragment of human growth hormone and has been discussed as a potential weight-loss agent based on theoretical mechanism. The fragment hypothesis — that…
-
Revisiting: How to bring a laboratory report to an appointment usefully Replied, post #153 · Clinical › Bloodwork · 28 Oct 2024 · 6 likes I read post #151 twice before replying, because I had assumed the opposite. TSH and free hormones: TSH is a reasonable screening test but does not tell you about actual…
-
Signs of dehydration worth acting on Replied, post #34 · Safety › Adverse events · 24 Oct 2024 · 7 likes Coming back to post #32, because the follow-up matters more than the original answer. Allergic reactions: true allergy (anaphylaxis, severe rash) is rare with these…
-
Revisiting: Melanocortin agonists: mechanism and the documented adverse profile Replied, post #53 · Compounds › Other compounds · 16 Oct 2024 · 0 likes Worth separating two things that post #49 runs together. AOD-9604 is a fragment of human growth hormone and has been discussed as a potential weight-loss agent based on…
-
Requesting a page: what makes a good request — what changed since Replied, post #11 · Documentation › Wiki requests · 9 Oct 2024 · 0 likes Format suggestions: if you think a maintained page could be clearer in its presentation (different section structure, different examples, added graphics) suggest the…
-
Coming back to: Preparing for an appointment: one page, three questions Replied, post #72 · Clinical › Prescriber conversations · 7 Oct 2024 · 0 likes post #71 is right about the mechanism and I think understates the practical bit. Prescription logistics: confirm whether it will be filled locally, requires mail order,…
-
Splitting a vial for two laboratories: how to do it without ruining both — what changed… Replied, post #54 · Sourcing › Independent verification · 12 Sep 2024 · 29 likes post #53 answers the question as asked. The question underneath it is different. VendorInvestigate: documentation and supplier-practice review. Reviews paperwork rather…
-
Where the four-week escalation interval comes from, and what it is not Replied, post #10 · Practice › Dosing & titration · 31 May 2024 · 0 likes Steady state means the plasma concentration is stable from dose to dose. That happens around 4 to 5 half-lives. Before that, the concentration is rising with each dose.…
-
Assessing a warm arrival: the decision process — one year on Replied, post #61 · Sourcing › Logistics · 30 May 2024 · 1 like On post #57 — agreed on the reasoning, with one qualification. Customs holds: if a parcel is held at customs and you can contact customs directly, declaring your…